{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:41:23Z","timestamp":1770331283221,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ajg.2020.09.005","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T09:58:10Z","timestamp":1612605490000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial"],"prefix":"10.1016","volume":"22","author":[{"given":"Xiao-Jian","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Peng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Shen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ajg.2020.09.005_b0005","article-title":"Review: Epidemiology of Helicobacter pylori infection","volume":"24","author":"Leja","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.ajg.2020.09.005_b0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajg.2017.05.002","article-title":"Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication","volume":"18","author":"Ozturk","year":"2017","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.ajg.2020.09.005_b0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2020.09.005_b0020","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.ajg.2020.09.005_b0025","article-title":"Review: treatment of Helicobacter pylori Infection 2019","volume":"24","author":"O'Connor","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.ajg.2020.09.005_b0030","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: a systematic review","volume":"19","author":"De Francesco","year":"2010","journal-title":"J Gastrointest Liver Dis"},{"key":"10.1016\/j.ajg.2020.09.005_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2020.09.005_b0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/MCG.0b013e31802e7ee7","article-title":"High Helicobacter pylori resistance rate to clarithromycin in Turkey","volume":"41","author":"Onder","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ajg.2020.09.005_b0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/1751-2980.12034","article-title":"Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection","volume":"14","author":"Liu","year":"2013","journal-title":"J Dig Dis"},{"key":"10.1016\/j.ajg.2020.09.005_b0050","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/apt.13346","article-title":"Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics","volume":"42","author":"Marcus","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2020.09.005_b0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/hel.12052","article-title":"Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy","volume":"18","author":"Liao","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.ajg.2020.09.005_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12475","article-title":"Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection","volume":"23","author":"Liu","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.ajg.2020.09.005_b0065","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/aps.2012.68","article-title":"Dose findings of antofloxacin hydrochloride for treating bacterial infections in an early clinical trial using PK-PD parameters in healthy volunteers","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ajg.2020.09.005_b0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000317581","article-title":"A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections","volume":"56","author":"Wang","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ajg.2020.09.005_b0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jgh.12442","article-title":"Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan","volume":"29","author":"Furuta","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2020.09.005_b0080","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s10620-017-4564-4","article-title":"Randomized clinical trial: esomeprazole, bismuth, levofloxacin, and amoxicillin or cefuroxime as first-line eradication regimens for Helicobacter pylori infection","volume":"62","author":"Fu","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajg.2020.09.005_b0085","first-page":"88","article-title":"Clarithromycin vs. gemifloxacin in quadruple therapy regimens for empiric primary treatment of Helicobacter pylori infection: a randomized clinical trial","volume":"7","author":"Masoodi","year":"2015","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.ajg.2020.09.005_b0090","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/AAC.01131-10","article-title":"Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies","volume":"55","author":"Liou","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajg.2020.09.005_b0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","article-title":"Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"381","author":"Liou","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajg.2020.09.005_b0100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1248\/bpb.25.923","article-title":"Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations","volume":"25","author":"Kita","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ajg.2020.09.005_b0105","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2020.09.005_b0110","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3748\/wjg.v21.i9.2786","article-title":"Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2020.09.005_b0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/hel.12046","article-title":"Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China","volume":"18","author":"Su","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.ajg.2020.09.005_b0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jphotobiol.2015.12.004","article-title":"Effect of C-5 position on the photochemical properties and phototoxicity of antofloxacin and levofloxacin: A stable and transient study","volume":"155","author":"Zhao","year":"2016","journal-title":"J Photochem Photobiol, B"},{"key":"10.1016\/j.ajg.2020.09.005_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/bdd.600","article-title":"Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers","volume":"29","author":"Xiao","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.ajg.2020.09.005_b0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/apt.13128","article-title":"Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments","volume":"41","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197920301106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197920301106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:42:48Z","timestamp":1761658968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197920301106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1687197920301106"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2020.09.005","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}